Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (61-70 of 263) with videos related to

Pageof 27
Sort By:
Biochemical Pharmacology|June 16, 1995
In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetronL Firkusny, H K Kroemer, M Eichelbaum
Lancet (London, England)|September 15, 1990
Polymorphic sulphoxidation of carbocisteineC O Meese, U Hofmann, M Eichelbaum
European Journal of Clinical Pharmacology|September 1, 1979
Influence of the defective metabolism of sparteine on its pharmacokineticsM Eichelbaum, N Spannbrucker, H J Dengler
Therapeutic Drug Monitoring|June 13, 2000
Disposition of propafenone in a poor metabolizer of CYP2D6 with Gilbert's syndromeK Dilger, P Meisel, U Hofmann, et al.
British Journal of Clinical Pharmacology|December 1, 1995
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactionsK T Kivistö, H K Kroemer, M Eichelbaum
British Journal of Clinical Pharmacology|December 15, 2004
Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. 1984B Vogelgesang, H Echizen, E Schmidt, et al.
Clinical Pharmacokinetics|November 1, 1988
No evidence of a genetic polymorphism in the oxidative metabolism of midazolamA Kassai, G Toth, M Eichelbaum, et al.
Clinical Pharmacokinetics|November 1, 1982
Application of stable labelled drugs in clinical pharmacokinetic investigationsM Eichelbaum, G E von Unruh, A Somogyi
European Journal of Clinical Pharmacology|January 1, 1991
Acute haemodynamic effects of i.v. nitrendipine in healthy subjectsG Mikus, C Zekorn, T Brecht, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1975
Proceedings: The physiological disposition of C14-verapamil in manM Schomerus, B Stieren, B Spiegelhalder, et al.
Pageof 27

Showing results (61-70 of 263) with videos related to

Sort By:
Pageof 27
Biochemical Pharmacology|June 16, 1995
In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetronL Firkusny, H K Kroemer, M Eichelbaum
Lancet (London, England)|September 15, 1990
Polymorphic sulphoxidation of carbocisteineC O Meese, U Hofmann, M Eichelbaum
European Journal of Clinical Pharmacology|September 1, 1979
Influence of the defective metabolism of sparteine on its pharmacokineticsM Eichelbaum, N Spannbrucker, H J Dengler
Therapeutic Drug Monitoring|June 13, 2000
Disposition of propafenone in a poor metabolizer of CYP2D6 with Gilbert's syndromeK Dilger, P Meisel, U Hofmann, et al.
British Journal of Clinical Pharmacology|December 1, 1995
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactionsK T Kivistö, H K Kroemer, M Eichelbaum
British Journal of Clinical Pharmacology|December 15, 2004
Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. 1984B Vogelgesang, H Echizen, E Schmidt, et al.
Clinical Pharmacokinetics|November 1, 1988
No evidence of a genetic polymorphism in the oxidative metabolism of midazolamA Kassai, G Toth, M Eichelbaum, et al.
Clinical Pharmacokinetics|November 1, 1982
Application of stable labelled drugs in clinical pharmacokinetic investigationsM Eichelbaum, G E von Unruh, A Somogyi
European Journal of Clinical Pharmacology|January 1, 1991
Acute haemodynamic effects of i.v. nitrendipine in healthy subjectsG Mikus, C Zekorn, T Brecht, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1975
Proceedings: The physiological disposition of C14-verapamil in manM Schomerus, B Stieren, B Spiegelhalder, et al.
Pageof 27